comparemela.com
  1. Home
  2. Live Updates
  3. Louise Batchelor Debra Daglish - Breaking News

Latest Breaking News On - Louise batchelor debra daglish - Page 3 : comparemela.com

VolitionRx Limited Announces Second Quarter 2023 Financial Results and Business Update

/PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the second quarter ended June.

United statesCity ofUnited kingdomTerig hughesTom buteraCameron reynoldsLouise batchelor debra daglishScott powellDrug administrationVolitionrx limited second quarterHeska corporationSecurities exchangeExchange commissionVolition veterinary diagnostics developmentCenters of excellenceToll international

VolitionRx Limited Schedules Second Quarter 2023 Earnings Conference Call and Business Update

/PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Tuesday, August 15 at 8.30 a.m. Eastern.

City ofUnited kingdomCameron reynoldsScott powellTom buteraTerig hughesLouise batchelor debra daglishVolition veterinary diagnostics developmentVolitionrx limited second quarterToll internationalPrnewswire volitionrx limitedBusiness update conference callGroup chief executive officerGroup chief financial officerChief executive officerExecutive vice president

VolitionRx Limited Announces Exercise of Over-Allotment Option by Underwriters

/PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announced today that the underwriters of its.

New yorkUnited statesCity ofUnited kingdomScott powellLouise batchelor debra daglishExchange commissionSecurities exchangePrnewswire volitionrx limitedCapital marketsBancroft capitalFreedom capital marketsDebra daglishSecurities actSecurities exchange actQuarterly reports

VolitionRx Limited Announces Closing of $16 5 Million Underwritten Public Offering of Common Stock

/PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announced today the closing of its previously.

City ofUnited kingdomUnited statesNew yorkScott powellLouise batchelor debra daglishVolitionrx limitedExchange commissionSecurities exchangeCapital marketsBancroft capitalFreedom capital marketsDebra daglishSecurities actSecurities exchange actQuarterly reports

VolitionRx Limited Announces Pricing of $16 5 Million Underwritten Public Offering of Common Stock

/PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today the pricing of an.

United statesCity ofUnited kingdomNew yorkScott powellLouise batchelor debra daglishPrnewswire volitionrx limitedSecurities exchangeExchange commissionCapital marketsBancroft capitalFreedom capital marketsDebra daglishSecurities actSecurities exchange actQuarterly reports

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.